On the basis of results obtained in our and in other labs it is now possible to affirm that B cells require different signals to be induced to IgE production. The first signal is delivered by the physical contact between T and B cells. Another important signal required for IgE synthesis is provided by the release of IL-4 by activated T cells. Other complementary signals can potentiate IgE synthesis. On the other hand, an inhibitory activity on IgE production is exerted by IFN-γ, IFN-α and TGF-β. The existence of human T cells with stable Th1 and Th2 functional pattern has been recently documented. Moreover, the importance of Th2-like cells in the pathogenesis of atopic diseases has been stressed by two lines of evidence. The first line refers to the selection of Th2-like cells by allergens; the second line concerns the accumulation of Th2-like cells in target organs of atopic diseases. Some data suggest that atopic patients display an aberrant production in vitro of IL-4 and IL-5 even in response to antigens other than allergens. The results obtained by studying the possible influence of microenvironmental cytokines support the view that IL-4, IFN-γ, IFN-α and TGF-β play reciprocal regulatory effects on the development of human Th1 and Th2 clones. Our results as well as other recent immunobiological acquisitions have raised the possibility that T lymphocytes, particularly Th2-like cells can play a central role in the pathogenesis of allergic inflammation. Through the release of different combinations of cytokines this kind of cells can represent, much better than any other cell, a common factor linking IgE production, eosinophils, mast cells, basophils and macrophages.

Keywords:
T cells, IgE, Cytokines
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.